The Department of Radiology at the University of Cambridge, in partnership with AstraZeneca, invites applications for a funded PhD studentship to develop an integrated pre-clinical pipeline for safety assessment of radioconjugates using in vivo PET imaging and multimodal ex vivo tissue analysis.
We seek a motivated student with a degree in imaging, biology, biochemistry, chemistry, biomedical sciences, pharmaceutical sciences, data analysis, or medicine, and who expects to obtain a UK first or
#J-18808-Ljbffr
PhD in Integrated Preclinical Safety for Radiopharmaceuticals in Cambridge employer: University of Cambridge
The University of Cambridge offers a dynamic and collaborative work environment, particularly within the Department of Oncology, where you will play a pivotal role in advancing cancer research. With a strong emphasis on employee growth, you will have access to professional development opportunities and the chance to work alongside leading experts in the field. The university's commitment to innovation and excellence ensures that your contributions will have a meaningful impact on clinical care and research outcomes.
